Skip to main content
Top
Published in: Journal of Urban Health 6/2013

01-12-2013

Factors Associated with Presence of Pharmacies and Pharmacies that Sell Syringes Over-the-Counter in Los Angeles County

Authors: Thomas J. Stopka, Estella M. Geraghty, Rahman Azari, Ellen B. Gold, Kathryn DeRiemer

Published in: Journal of Urban Health | Issue 6/2013

Login to get access

Abstract

Community pharmacies serve as key locations for public health services including interventions to enhance the availability of syringes sold over-the-counter (OTC), an important strategy to prevent injection-mediated HIV transmission. Little is known about the community characteristics associated with the availability of pharmacies and pharmacies that sell syringes OTC. We conducted multivariable regression analyses to determine whether the sociodemographic characteristics of census tract residents were associated with pharmacy presence in Los Angeles (LA) County during 2008. Using a geographic information system, we conducted hot-spot analyses to identify clusters of pharmacies, OTC syringe-selling pharmacies, sociodemographic variables, and their relationships. For LA County census tracts (N = 2,054), population size (adjusted odds ratio [AOR], 1.22; 95 % confidence interval [CI], 1.16, 1.28), median age of residents (AOR, 1.03; 95 % CI, 1.01, 1.05), and the percent of households receiving public assistance (AOR, 0.97; 95 % CI, 0.94, 0.99) were independently associated with the presence of all pharmacies. Only 12 % of census tracts had at least one OTC syringe-selling pharmacy and sociodemographic variables were not independently associated with the presence of OTC syringe-selling pharmacies. Clusters of pharmacies (p < 0.01) were located proximally to clusters of older populations and were distant from clusters of poorer populations. Our combined statistical and spatial analyses provided an innovative approach to assess the sociodemographic and geographic factors associated with the presence of community pharmacies and pharmacies that participate in OTC syringe sales.
Appendix
Available only for authorised users
Literature
1.
go back to reference Negru DS, Diaconescu M, Petculescu AM, Bild V. Community pharmacy—ideal location to screen and monitor hypertensive patients. Rev Med Chir Soc Med Nat Iasi. 2010; 114(3): 904–909.PubMed Negru DS, Diaconescu M, Petculescu AM, Bild V. Community pharmacy—ideal location to screen and monitor hypertensive patients. Rev Med Chir Soc Med Nat Iasi. 2010; 114(3): 904–909.PubMed
2.
go back to reference Skiles MP, Cai J, English A, Ford CA. Retail pharmacies and adolescent vaccination—an exploration of current issues. J Adolesc Health. 2011; 48(6): 630–632.PubMedCrossRef Skiles MP, Cai J, English A, Ford CA. Retail pharmacies and adolescent vaccination—an exploration of current issues. J Adolesc Health. 2011; 48(6): 630–632.PubMedCrossRef
3.
go back to reference Fitzgerald N, Watson H, McCaig D, Stewart D. Developing and evaluating training for community pharmacists to deliver interventions on alcohol issues. Pharm World Sci. 2009; 31(2): 149–153.PubMedCrossRef Fitzgerald N, Watson H, McCaig D, Stewart D. Developing and evaluating training for community pharmacists to deliver interventions on alcohol issues. Pharm World Sci. 2009; 31(2): 149–153.PubMedCrossRef
4.
go back to reference Deas C, McCree DH. Pharmacists and HIV/AIDS prevention: review of the literature. J Am Pharm Assoc. 2003; 50(3): 411–415. Deas C, McCree DH. Pharmacists and HIV/AIDS prevention: review of the literature. J Am Pharm Assoc. 2003; 50(3): 411–415.
5.
go back to reference Fuller C, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007; 97(1): 117–124.PubMedCrossRef Fuller C, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007; 97(1): 117–124.PubMedCrossRef
6.
go back to reference Rudolph AE, Standish K, Amesty S, et al. A community-based approach to linking injection drug users with needed services through pharmacies: an evaluation of a pilot intervention in New York City. AIDS Educ Prev. 2010; 22(3): 238–251.PubMedCrossRef Rudolph AE, Standish K, Amesty S, et al. A community-based approach to linking injection drug users with needed services through pharmacies: an evaluation of a pilot intervention in New York City. AIDS Educ Prev. 2010; 22(3): 238–251.PubMedCrossRef
7.
go back to reference Deibert R, Goldbaum G, Parker T, et al. Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003. Am J Public Health. 2006; 96(8): 1347–1353.PubMedCrossRef Deibert R, Goldbaum G, Parker T, et al. Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003. Am J Public Health. 2006; 96(8): 1347–1353.PubMedCrossRef
8.
go back to reference Valleroy L, Weinstein B, Jones T, Groseclose S, Rolfs R, Kassler W. Impact of increased legal access to needles and syringes on community pharmacies’ needle and syringe sales—Connecticut, 1992–1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 10(1): 73–81.PubMed Valleroy L, Weinstein B, Jones T, Groseclose S, Rolfs R, Kassler W. Impact of increased legal access to needles and syringes on community pharmacies’ needle and syringe sales—Connecticut, 1992–1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 10(1): 73–81.PubMed
9.
go back to reference Burris S, Welsh J, Ng M, Li M, Ditzler A. State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S94–S98. Burris S, Welsh J, Ng M, Li M, Ditzler A. State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S94–S98.
10.
go back to reference Singer M, Baer H, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Rep. 1998; 113(Suppl 1): 81–89.PubMed Singer M, Baer H, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Rep. 1998; 113(Suppl 1): 81–89.PubMed
11.
go back to reference Junge B, Vlahov D, Riley E, Huettner S, Brown M, Beilenson P. Pharmacy access to sterile syringes for injection drug users: attitudes of participants in a syringe exchange program. J Am Pharm Assoc (Wash). 1999; 39(1): 17–22. Junge B, Vlahov D, Riley E, Huettner S, Brown M, Beilenson P. Pharmacy access to sterile syringes for injection drug users: attitudes of participants in a syringe exchange program. J Am Pharm Assoc (Wash). 1999; 39(1): 17–22.
12.
go back to reference Compton W, Horton J, Cottler L, et al. A multistate trial of pharmacy syringe purchase. J Urban Health. 2004; 81(4): 661–670.PubMedCrossRef Compton W, Horton J, Cottler L, et al. A multistate trial of pharmacy syringe purchase. J Urban Health. 2004; 81(4): 661–670.PubMedCrossRef
13.
go back to reference Fuller C, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S77–S82. Fuller C, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S77–S82.
14.
go back to reference Bluthenthal R, Kral A, Gee L, Erringer E, Edlin B. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS. 2000; 14(5): 605–611.PubMedCrossRef Bluthenthal R, Kral A, Gee L, Erringer E, Edlin B. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS. 2000; 14(5): 605–611.PubMedCrossRef
15.
go back to reference Hurley S, Jolley D, Kaldor J. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997; 349(9068): 1797–1800.PubMedCrossRef Hurley S, Jolley D, Kaldor J. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997; 349(9068): 1797–1800.PubMedCrossRef
16.
go back to reference MacDonald M, Law M, Kaldor J, Hales JGD. Effectiveness of needle and syringe programs for preventing HIV transmission. Int J Drug Policy. 2003; 14(5/6): 353–357.CrossRef MacDonald M, Law M, Kaldor J, Hales JGD. Effectiveness of needle and syringe programs for preventing HIV transmission. Int J Drug Policy. 2003; 14(5/6): 353–357.CrossRef
17.
go back to reference Pouget E, Deren S, Fuller C, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr. 2005; 39(4): 471–477.PubMedCrossRef Pouget E, Deren S, Fuller C, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr. 2005; 39(4): 471–477.PubMedCrossRef
18.
go back to reference Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006; 41(6–7): 777–813.PubMedCrossRef Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006; 41(6–7): 777–813.PubMedCrossRef
19.
go back to reference Neaigus A, Zhao M, Gyarmathy V, Cisek L, Friedman S, Baxter R. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal. J Urban Health. 2008; 85(3): 309–322.PubMedCrossRef Neaigus A, Zhao M, Gyarmathy V, Cisek L, Friedman S, Baxter R. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal. J Urban Health. 2008; 85(3): 309–322.PubMedCrossRef
20.
go back to reference Friedman S, Perlis T, Des Jarlais D. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health. 2001; 91(5): 791–793.PubMedCrossRef Friedman S, Perlis T, Des Jarlais D. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health. 2001; 91(5): 791–793.PubMedCrossRef
21.
go back to reference Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996; 86(5): 642–654.PubMedCrossRef Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996; 86(5): 642–654.PubMedCrossRef
22.
go back to reference Jones T, Coffin P. Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S6–S9. Jones T, Coffin P. Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S6–S9.
23.
go back to reference Reich W, Compton W, Horton J, et al. Injection drug users report good access to pharmacy sale of syringes. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S68–S72. Reich W, Compton W, Horton J, et al. Injection drug users report good access to pharmacy sale of syringes. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S68–S72.
24.
go back to reference Riley E, Safaeian M, Strathdee S, et al. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. J Acquir Immune Defic Syndr. 2000; 24(1): 57–61.PubMed Riley E, Safaeian M, Strathdee S, et al. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. J Acquir Immune Defic Syndr. 2000; 24(1): 57–61.PubMed
25.
go back to reference Stopka T, Garfein R, Ross A, Truax S. Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel. J Urban Health. 2007; 84(1): 116–125.PubMedCrossRef Stopka T, Garfein R, Ross A, Truax S. Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel. J Urban Health. 2007; 84(1): 116–125.PubMedCrossRef
26.
go back to reference Garfein RS, Stopka TJ, Pavlinac PB, et al. Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now? J Urban Health. 2010; 87(4): 576–585.PubMedCrossRef Garfein RS, Stopka TJ, Pavlinac PB, et al. Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now? J Urban Health. 2010; 87(4): 576–585.PubMedCrossRef
27.
go back to reference Riley ED, Kral AH, Stopka TJ, Garfein RS, Reuckhaus P, Bluthenthal RN. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. J Urban Health. 2010; 87(4): 534–542.PubMedCrossRef Riley ED, Kral AH, Stopka TJ, Garfein RS, Reuckhaus P, Bluthenthal RN. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. J Urban Health. 2010; 87(4): 534–542.PubMedCrossRef
28.
go back to reference Kaplan RS, Leinhardt S. The spatial distribution of urban pharmacies. Med Care. 1975; 13(1): 37–46.PubMedCrossRef Kaplan RS, Leinhardt S. The spatial distribution of urban pharmacies. Med Care. 1975; 13(1): 37–46.PubMedCrossRef
29.
go back to reference Schommer JC, Singh RL, Cline RR, Hadsall RS. Market dynamics of community pharmacies in Minnesota. Res Soc Adm Pharm. 2006; 2(3): 347–358.CrossRef Schommer JC, Singh RL, Cline RR, Hadsall RS. Market dynamics of community pharmacies in Minnesota. Res Soc Adm Pharm. 2006; 2(3): 347–358.CrossRef
30.
go back to reference Doucette WR, Brooks JM, Sorofman BA, Wong H. Market factors and the availability of community pharmacies. Clin Ther. 1999; 21(7): 1267–1279. discussion 1266.PubMedCrossRef Doucette WR, Brooks JM, Sorofman BA, Wong H. Market factors and the availability of community pharmacies. Clin Ther. 1999; 21(7): 1267–1279. discussion 1266.PubMedCrossRef
31.
go back to reference Cooper HL, Bossak BH, Tempalski B, Friedman SR, Des Jarlais DC. Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need. J Urban Health. 2009; 86(6): 929–945.PubMedCrossRef Cooper HL, Bossak BH, Tempalski B, Friedman SR, Des Jarlais DC. Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need. J Urban Health. 2009; 86(6): 929–945.PubMedCrossRef
35.
go back to reference Ord J, Getis A. Local spatial autocorrelation statistics: distributional issues and an application. Geogr Anal. 1995; 27: 286–306.CrossRef Ord J, Getis A. Local spatial autocorrelation statistics: distributional issues and an application. Geogr Anal. 1995; 27: 286–306.CrossRef
36.
go back to reference Mitchell A. The ESRI Guide to GIS Analysis Volume 2: Spatial Measurements and Statistics, vol. 2. Redlands, CA: ESRI Press; 2005. Mitchell A. The ESRI Guide to GIS Analysis Volume 2: Spatial Measurements and Statistics, vol. 2. Redlands, CA: ESRI Press; 2005.
Metadata
Title
Factors Associated with Presence of Pharmacies and Pharmacies that Sell Syringes Over-the-Counter in Los Angeles County
Authors
Thomas J. Stopka
Estella M. Geraghty
Rahman Azari
Ellen B. Gold
Kathryn DeRiemer
Publication date
01-12-2013
Publisher
Springer US
Published in
Journal of Urban Health / Issue 6/2013
Print ISSN: 1099-3460
Electronic ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-013-9798-7

Other articles of this Issue 6/2013

Journal of Urban Health 6/2013 Go to the issue